Page last updated: 2024-08-18

4-butyrolactone and Pulmonary Arterial Hypertension

4-butyrolactone has been researched along with Pulmonary Arterial Hypertension in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chen, J; Chen, S; Hou, C; Lin, S; Niu, Y; Sun, X; Xiao, T; Xie, L; Zhao, Y; Zong, Y1

Other Studies

1 other study(ies) available for 4-butyrolactone and Pulmonary Arterial Hypertension

ArticleYear
The Emerging Role of Fatty Acid Synthase in Hypoxia-Induced Pulmonary Hypertensive Mouse Energy Metabolism.
    Oxidative medicine and cellular longevity, 2021, Volume: 2021

    Topics: 4-Butyrolactone; Animals; Apoptosis; Energy Metabolism; Fatty Acid Synthases; Hypoxia; Mice; Mice, Inbred C57BL; Mitochondria; Myocytes, Smooth Muscle; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Pulmonary Arterial Hypertension; Signal Transduction

2021